Moreover, in the patient cohort analysis, patients with high SMYD2 expression had a poor prognosis in terms of recurrence- and metastasis-free survival, implying that SMYD2 function is strongly related to lung cancer proliferation and metastasis (Fig. 1c). This evidence concerns the gene SMYD2 and lung cancer.